Yahoo Web Search

Search results

1. pmc.ncbi.nlm.nih.gov › articles › PMC10905744Update on current and new potential immunotherapies in breast ...

   pmc.ncbi.nlm.nih.gov › articles › PMC10905744

   Although breast cancer (BC) has been long considered as non-immunogenic, immunotherapy for the treatment of BC is now emerging as a new promising therapeutic approach with considerable potential. This is supported by a plethora of completed and ongoing preclinical and clinical studies in various types of immunotherapies.

2. onlinelibrary.wiley.com › doi › fullClinical outcomes of breast cancer patients treated in phase ...

   onlinelibrary.wiley.com › doi › full

   Oct 16, 2020 · Abstract. Patients with metastatic breast cancer (MBC) refractory to standard of care therapies have a poor prognosis. The purpose of this study was to assess patient characteristics and clinical outcomes for patients with MBC treated on phase I clinical trials.

   • Author: Jennifer A Weiss, Andrew Nicklawsky, Jodi A Kagihara, Dexiang Gao, Christine Fisher, Anthony Elias, ...

   • Publish Year: 2020

3. www.nature.com › articles › s41573/022/00579-0Targeting HER2-positive breast cancer: advances and future ...

   www.nature.com › articles › s41573/022/00579-0

   Nov 7, 2022 · The long-sought discovery of HER2 as an actionable and highly sensitive therapeutic target was a major breakthrough for the treatment of highly aggressive HER2-positive breast cancer, leading...

4. www.breastcanceruk.org.uk › about-breast-cancerFacts and figures - Breast Cancer UK

   www.breastcanceruk.org.uk › about-breast-cancer

   • Cached

   Facts and figures. In 2022, 11.6% of all cancers diagnosed were female breast cancer, making it the second most common cancer worldwide (1). In 2022, there were around 2.3 million women diagnosed with breast cancer and 666,000 deaths globally, making it the leading cause of cancer deaths among women (1).

5. acsjournals.onlinelibrary.wiley.com › doi › fullBreast cancer patient advocacy: A qualitative study of the ...

   acsjournals.onlinelibrary.wiley.com › doi › full

   Apr 29, 2020 · Breast cancer advocacy movements, driven by patient advocate–led civil society organizations (CSO), have proven to be a powerful force for the advancement of cancer control in high-income countries (HICs).

   • Author: Allison Dvaladze, Allison Dvaladze, Darya A. Kizub, Anna Cabanes, Gertrude Nakigudde, Bertha Aguilar...
   • Cited By: 6

   • Publish Year: 2020
   • Published: 29 April 2020

6. pmc.ncbi.nlm.nih.gov › articles › PMC9465273Current and future burden of breast cancer: Global statistics ...

   pmc.ncbi.nlm.nih.gov › articles › PMC9465273

   The future burden of breast cancer in 2040. By 2040, the number of newly diagnosed breast cancers is projected to grow by over 40%, to about 3 million cases every year. Similarly, deaths from breast cancer are set out to increase more than 50%, from 685,000 in 2020 to 1 million in 2040 (Fig. 4).

7. People also ask

   Are breast cancer patient advocacy movements growing in low-income and middle-income countries?

   • Breast cancer patient advocacy movements are growing in low-income and middle-income countries (LMICs) in response to an increasing cancer burden and significant disparities in outcomes; however, today's cancer control environment differs notably from that encountered by their 20th century predecessors.

   Breast cancer patient advocacy: A qualitative study of the challenges

   acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.32852

   See all results for this question

   How many women are screened for breast cancer in 2020-2021?

   • There was a 44% decrease in the number of women (45 and over) who were screened for breast cancer in 2020-2021 (1.19 million), compared to 2019-2020 (2.12 million) (14).

   Facts and figures - Breast Cancer UK

   www.breastcanceruk.org.uk/about-breast-cancer/facts-figures-and-qas/facts-and-figures/

   See all results for this question

   Do coalitions and regional networks promote breast cancer advocacy in LMICs?

   • To the authors' knowledge, the current study is the first to describe the role that coalitions and regional networks play in advancing breast cancer advocacy in LMICs across multiple regions. The findings of the current study corroborate the importance of investing in 3-way partnerships between CSOs, political leaders, and health experts.

   Breast cancer patient advocacy: A qualitative study of the challenges

   acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.32852

   See all results for this question

   How did cancer change Doby's perspective on life?

   • Cancer changed Doby's perspective on life. "There is a sense of clarity that came with my cancer diagnosis. Given the unique opportunity to stare mortality in the face, everything simplified," she says. "The fast living, the need for more, the urge to fix and mold an experience into something other than what it is takes me out of the moment.

   Six Breast Cancer Survivors Share Their Powerful Stories

   www.allure.com/story/breast-cancer-survivors-stories

   See all results for this question

8. www.allure.com › story › breast-cancer-survivors-storiesSix Breast Cancer Survivors Share Their Powerful Stories

   www.allure.com › story › breast-cancer-survivors-stories

   Oct 14, 2020 · Six breast cancer survivors share their stories of pain and perseverance, of strength and survival, and of learning to find beauty in oneself. By Kristin Booker. October 14, 2020. Designed by...